key: cord-1022749-iz5umwx7
authors: Allen, Matthew B.; Neal, Joseph M.; Vlassakov, Kamen
title: Neuraxial anaesthesia in the context of bacterial meningitis and COVID-19
date: 2020-09-09
journal: Br J Anaesth
DOI: 10.1016/j.bja.2020.09.008
sha: 6bb91259251be9ef9150e4f9c2a7472c35f35ed7
doc_id: 1022749
cord_uid: iz5umwx7

nan

spinal fluid (CSF) with 1+ GPC in pairs, and culture grew MSSA. After patient-inclusive discussion of anaesthetic options, left knee arthrotomy, drainage, and liner exchange under spinal anaesthesia was planned. The patient demonstrated understanding of the risks and benefits, endorsed a preference for neuraxial anaesthesia, and gave informed consent.

In the operating room, levofloxacin i.v. was administered as additional antimicrobial prophylaxis. A 17G Tuohy needle was sterilely introduced at the L3-4 interspace. Flow of straw-colored CSF was obtained at a depth of 9 cm and a multiport catheter was threaded to 14 cm to facilitate titration of local anaesthetic, and 5 mL mepivacaine 1.5% was incrementally injected, titrated to resolution of pain and complete sensorimotor block of the lower extremities, resulting in a T8 sensory level. He remained haemodynamically stable. The 90-min surgery was uncomplicated with minimal blood loss. The patient wore a surgical mask and received oxygen 2 L min -1 via nasal cannula to maintain SpO 2 > 92%. The spinal catheter was removed at the end of the procedure. Postoperatively, he experienced no postdural puncture headache or other complications.

Neuraxial anaesthesia is contraindicated in patients with bacteraemia, epidural abscess, or meningitis. 3 Neuraxial anaesthesia in infected patients should be considered routine, this case provides a justifiable exception based on analysis of risks and benefits and competing interests. As noted in a recent editorial, "It is reasonable to consider administering regional anaesthesia to patients at higher risk of complications simply to avoid general anaesthesia during the pandemic." 2 In COVID-19, concerns surrounding general anaesthesia include risks to staff (viral transmission) and to the patient (precipitating respiratory failure). 4-6 Patient safety was our paramount concern. History of obesity, smoking, and viral respiratory infection increased this patient's risk for pulmonary complications. Moreover, deleterious effects of general anaesthesia and mechanical ventilation could be exacerbated in the setting of COVID-19 given its unpredictable and potentially lethal course. 5, 6 Concerns regarding neuraxial anaesthesia were considered. Because the blood, epidural space, and CSF were already infected, additional harm from repeat dural puncture was thought to be justifiably low. Intrathecal and meningeal inflammation raised theoretical uncertainties regarding J o u r n a l P r e -p r o o f efficacy and duration of spinal anaesthesia. 7 We administered mepivacaine because of its low pKa and threaded an intrathecal catheter to facilitate titration to effect. Preparations were made to convert to general anaesthesia and secure the airway if necessary. 8

Alternative regional anaesthesia techniques were discussed with the surgical team and the patient. Peripheral nerve blocks were deemed inferior due to 1) challenges with positioning and ultrasound visualization related to the patient's obesity and inability to tolerate lower extremity manipulation, 2) need for multiple blocks requiring nearly maximal doses of local anaesthetic, 3) slower onset, and 4) less predictable extent of sensory and motor blockade deemed essential by the surgical team. Efficacy of epidural, combined spinal-epidural or single shot spinal anaesthesia was considered unpredictable due to epidural and intrathecal infection. Given these variables, intrathecal titration of local anaesthetic appeared to optimise chances of success.

In the setting of COVID-19, the indications for regional anesthesia have expanded, and relative contraindications relaxed based on relative risk assessment.

The authors declare no conflicts of interest.

Practice Recommendations on Neuraxial Anesthesia and Peripheral Nerve Blocks during the COVID-19 Pandemic. A Joint Statement by the American Society of Regional Anesthesia and Pain Medicine (ASRA) and European Society of Regional Anesthesia and Pain Therapy (ESRA)

Regional anaesthesia and COVID-19: first choice at last?

American Society of Anesthesiologists Task Force on infectious complications associated with neuraxial techniques: Practice advisory for the prevention, diagnosis, and management J o u r n a l P r e -p r o o f of infectious complications associated with neuraxial techniques: A report by the American Society of Anesthesiologists Task Force on infectious complications associated with neuraxial techniques

Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

The Science of Local Anesthesia: Basic Research, Clinical Application, and Future Directions

Perioperative Management of Patients Infected with the Novel Coronavirus: Recommendation from the Joint Task Force of the Chinese Society of Anesthesiology and the Chinese Association of Anesthesiologists